Amid global demand for Hydroxychloroquine, Govt issues new advisory on who should avoid it


The government advisory has recommended not administering the drug to children below the age of 15 and people with known case of retinopathy and known hypersensitivity to Hydroxychloroquine or 4-aminoquinoline compounds.

SNS Web | New Delhi | April 10, 2020 The StatesmanHydroxychloroquine

Ever since the deadly virus spread across nations, Hydroxychloroquine has become one of the most highly demanded drugs worldwide. (Representational Photo: iStock)

The Union Health Ministry on Friday issued a fresh advisory on the use of Hydroxychloroquine (HCQ), a key anti-malaria drug, seen as a possible cure for COVID-19 coronavirus infection.

The ministry has stated that HCQ is recommended only under exceptional circumstances and for the protection of high-risk individuals as the drug was found to be effective against Coronavirus only in pre-clinical laboratory studies.

The advisory is based on recommendation of the task force constituted by the Indian Council of Medical Research (ICMR).